DULOXETINE HYDROCHLORIDE | N219131 | ALMATICA PHARMA LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Kathy Lynn Bramel Easterday FDA-2026-P-1831 · 3 docket documents Kathy Lynn Bramel Easterday filed this petition under sections 502, 505, 701, and related provisions of the Federal Food, Drug, and Cosmetic Act requesting that the FDA Commissioner require NDA holders and generic manufacturers of Cymbalta (duloxetine hydrochloride) to develop and make available sta | 505(q) | 2026-02-19 | Open | Kathy Lynn Bramel Easterday |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.